Nesidioblastoma: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
[[Category:Cancer]] | [[Category:Cancer]] | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 19:48, 17 March 2025
Nesidioblastoma is a rare form of pancreatic tumor that is derived from the islet cells of the pancreas. It is also known as islet cell carcinoma or pancreatic neuroendocrine tumor (PNET).
Overview[edit]
Nesidioblastoma is a type of neoplasm that originates from the islet cells of the pancreas. These cells are responsible for producing insulin, a hormone that regulates the amount of glucose in the blood. When these cells become cancerous, they can form a tumor known as a nesidioblastoma.
Symptoms[edit]
The symptoms of nesidioblastoma can vary depending on the size and location of the tumor. Common symptoms may include abdominal pain, weight loss, and jaundice. In some cases, the tumor may produce excess amounts of insulin, leading to low blood sugar levels (hypoglycemia).
Diagnosis[edit]
The diagnosis of nesidioblastoma typically involves a combination of physical examination, medical history, and imaging tests such as CT scan or MRI. In some cases, a biopsy may be performed to confirm the diagnosis.
Treatment[edit]
The treatment for nesidioblastoma usually involves surgery to remove the tumor. In some cases, chemotherapy or radiation therapy may also be used. The choice of treatment depends on the size and location of the tumor, as well as the patient's overall health.
Prognosis[edit]
The prognosis for nesidioblastoma can vary widely depending on the stage of the disease at the time of diagnosis. Early detection and treatment can significantly improve the prognosis.
See also[edit]
References[edit]
<references />


